82

Gastroenterology
Focuses on gastrointestinal health.
Sub Categories on Gastroenterology
Latest Articles
Waking up to the hidden struggles of inflammatory bowel diseases

Waking up to the hidden struggles of inflammatory bowel diseases

byFlinders UniversityLatent profiles of determinants of fatigue. Credit:BMC Gastroenterology(2024). DOI: 10.1186/s12876-024-03239-2Helping people with inflammatory bowel diseases to

Waking up to the hidden struggles of inflammatory bowel diseases

byFlinders UniversityLatent profiles of determinants of fatigue. Credit:BMC Gastroenterology(2024). DOI: 10.1186/s12876-024-03239-2Helping people with inflammatory bowel diseases to
Four tips to keeping your gut healthy and free of IBD

Four tips to keeping your gut healthy and free of IBD

by Ernie MundellAlmost2.4 million Americansare thought to suffer from the pain and disability of inflammatory bowel disorder (IBD), a type of autoimmune illness that includes ulcerative co

Four tips to keeping your gut healthy and free of IBD

by Ernie MundellAlmost2.4 million Americansare thought to suffer from the pain and disability of inflammatory bowel disorder (IBD), a type of autoimmune illness that includes ulcerative co
Antireflux mucosectomy, mucosal ablation compared for gastroesophageal reflux disease

Antireflux mucosectomy, mucosal ablation compared for gastroesophageal reflux disease

by Elana GotkineFor patients with gastroesophageal reflux disease (GERD), improvement in symptoms is seen with both antireflux mucosectomy (ARMS) and antireflux mucosal ablation (ARMA), but subjective

Antireflux mucosectomy, mucosal ablation compared for gastroesophageal reflux disease

by Elana GotkineFor patients with gastroesophageal reflux disease (GERD), improvement in symptoms is seen with both antireflux mucosectomy (ARMS) and antireflux mucosal ablation (ARMA), but subjective
Study identifies a new disease-inducing mechanism for inflammatory bowel disease

Study identifies a new disease-inducing mechanism for inflammatory bowel disease

byNewcastle UniversityMicrograph showing inflammation of the large bowel in a case of inflammatory bowel disease. Colonic biopsy. Credit: Wikipedia/CC BY-SA 3.0Interleukin-10 (IL-10) is an anti-

Study identifies a new disease-inducing mechanism for inflammatory bowel disease

byNewcastle UniversityMicrograph showing inflammation of the large bowel in a case of inflammatory bowel disease. Colonic biopsy. Credit: Wikipedia/CC BY-SA 3.0Interleukin-10 (IL-10) is an anti-
A Special Base Editor: Modifying Gut Bacteria Genes

A Special Base Editor: Modifying Gut Bacteria Genes

Credit:www.freepik.com“We have always dreamed of achieving this.” — Xavier Duportet, co-founder of the French biotechnology company Eligo Bioscience and synthetic biologistOn July 10, 2024, a technica

A Special Base Editor: Modifying Gut Bacteria Genes

Credit:www.freepik.com“We have always dreamed of achieving this.” — Xavier Duportet, co-founder of the French biotechnology company Eligo Bioscience and synthetic biologistOn July 10, 2024, a technica
'We have treatments': Doctors urge patients with chronic vomiting to not suffer in silence

'We have treatments': Doctors urge patients with chronic vomiting to not suffer in silence

byAmerican Gastroenterological AssociationCredit: CC0 Public DomainThe American Gastroenterological Association (AGA) has released new clinical guidance to help clinicians and patients recognize

'We have treatments': Doctors urge patients with chronic vomiting to not suffer in silence

byAmerican Gastroenterological AssociationCredit: CC0 Public DomainThe American Gastroenterological Association (AGA) has released new clinical guidance to help clinicians and patients recognize
Subcutaneous therapy improves inflammatory bowel disease treatment, clinical trial finds

Subcutaneous therapy improves inflammatory bowel disease treatment, clinical trial finds

by Melissa Rohman,Northwestern UniversityLinear scale mean (SD) serum infliximab concentrations up to week 54 (PK population) in the CD (A) and UC (B) studies. Concentrations below the lower lim

Subcutaneous therapy improves inflammatory bowel disease treatment, clinical trial finds

by Melissa Rohman,Northwestern UniversityLinear scale mean (SD) serum infliximab concentrations up to week 54 (PK population) in the CD (A) and UC (B) studies. Concentrations below the lower lim